BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

614 related articles for article (PubMed ID: 20463591)

  • 1. Coexisting hepatopulmonary syndrome and portopulmonary hypertension: implications for liver transplantation.
    Pham DM; Subramanian R; Parekh S
    J Clin Gastroenterol; 2010 Aug; 44(7):e136-40. PubMed ID: 20463591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary vascular abnormalities in cirrhosis.
    Herve P; Le Pavec J; Sztrymf B; Decante B; Savale L; Sitbon O
    Best Pract Res Clin Gastroenterol; 2007; 21(1):141-59. PubMed ID: 17223502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver transplantation in high-risk patients: hepatopulmonary syndrome and portopulmonary hypertension.
    Martínez-Palli G; Taurà P; Balust J; Beltrán J; Zavala E; Garcia-Valdecasas JC
    Transplant Proc; 2005 Nov; 37(9):3861-4. PubMed ID: 16386564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatopulmonary syndrome and portopulmonary hypertension in the model for end-stage liver disease (MELD) era.
    Mandell MS
    Liver Transpl; 2004 Oct; 10(10 Suppl 2):S54-8. PubMed ID: 15382220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatopulmonary syndrome and portopulmonary hypertension.
    Restrepo R; Singer EF; Baram M; Restrepo R; Singer EF; Baram M
    Hosp Pract (1995); 2013 Apr; 41(2):62-71. PubMed ID: 23680738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary hypertension after liver transplantation in patients with antecedent hepatopulmonary syndrome: a report of 2 cases and review of the literature.
    Aucejo F; Miller C; Vogt D; Eghtesad B; Nakagawa S; Stoller JK
    Liver Transpl; 2006 Aug; 12(8):1278-82. PubMed ID: 16937330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary Complications of Portal Hypertension.
    Cartin-Ceba R; Krowka MJ
    Clin Liver Dis; 2019 Nov; 23(4):683-711. PubMed ID: 31563218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review: hepatopulmonary syndrome and portopulmonary hypertension.
    De Coninck S; Van Vlierberghe H; De Vos M; Elewaut A
    Acta Gastroenterol Belg; 2001; 64(3):286-94. PubMed ID: 11680050
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic options in pulmonary hepatic vascular diseases.
    Horvatits T; Fuhrmann V
    Expert Rev Clin Pharmacol; 2014 Jan; 7(1):31-42. PubMed ID: 24308785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Portopulmonary hypertension and hepatopulmonary syndrome.
    Hoeper MM; Krowka MJ; Strassburg CP
    Lancet; 2004 May; 363(9419):1461-8. PubMed ID: 15121411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatopulmonary syndrome and portopulmonary hypertension: implications for liver transplantation.
    Krowka MJ
    Clin Chest Med; 2005 Dec; 26(4):587-97, vi. PubMed ID: 16263398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary complications in liver disease.
    Sen S; Alexander GJ
    Br J Hosp Med (Lond); 2009 Dec; 70(12):685-91. PubMed ID: 20081613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolving dilemmas and management of portopulmonary hypertension.
    Krowka MJ
    Semin Liver Dis; 2006 Aug; 26(3):265-72. PubMed ID: 16850376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatopulmonary syndrome and portopulmonary hypertension: recent knowledge in pathogenesis and overview of clinical assessment.
    Raevens S; Geerts A; Van Steenkiste C; Verhelst X; Van Vlierberghe H; Colle I
    Liver Int; 2015 Jun; 35(6):1646-60. PubMed ID: 25627425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary complications of cirrhosis.
    Singh C; Sager JS
    Med Clin North Am; 2009 Jul; 93(4):871-83, viii. PubMed ID: 19577119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Portopulmonary hypertension and hepatopulmonary syndrome: a clinician-oriented overview.
    Porres-Aguilar M; Altamirano JT; Torre-Delgadillo A; Charlton MR; Duarte-Rojo A
    Eur Respir Rev; 2012 Sep; 21(125):223-33. PubMed ID: 22941887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pulmonary complication of liver disease].
    Dollinger MM
    Praxis (Bern 1994); 2006 Oct; 95(40):1539-42. PubMed ID: 17048411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to Sildenafil in a Patient With Coexisting Post-Liver Transplant Portopulmonary Hypertension and Hepatopulmonary Syndrome.
    Turgeon RD; Hussaini T; Partovi N; Erb SR; Nador R; Marquez Azalgara V; Yoshida E
    Exp Clin Transplant; 2017 Dec; 15(6):693-695. PubMed ID: 27001306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database.
    Krowka MJ; Mandell MS; Ramsay MA; Kawut SM; Fallon MB; Manzarbeitia C; Pardo M; Marotta P; Uemoto S; Stoffel MP; Benson JT
    Liver Transpl; 2004 Feb; 10(2):174-82. PubMed ID: 14762853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pulmonary complications of hepatic cirrhosis: portopulmonary hypertension and hepatopulmonary syndrome. The paradox of pulmonary vasoconstriction and vasodilation].
    Chávez-Tapia NC; Uribe M; López E
    Gac Med Mex; 2007; 143(4):333-9. PubMed ID: 17969842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.